Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Exploration of Targeted Anti-Tumor Therapy
|
November 10, 2025
Bispecific antibodies in the treatment of epithelial ovarian, endometrial, and cervical cancer: an overview of current applications, challenges, and emerging opportunities
Sara Parola, Ilaria Colombo
Mediastinum (Hong Kong, China)
|
February 4, 2022
Mediastinal soft tissue sarcoma: dark sides and future lights
Giovannella Palmieri, Marianna Tortora, Sara Parola, et al.
Frontiers in Oncology
|
August 21, 2023
Long-term complete response with third-line PARP inhibitor after immunotherapy in a patient with triple-negative breast cancer: a case report
Roberta Caputo, Martina Pagliuca, Matilde Pensabene, et al.
Eclinicalmedicine
|
August 9, 2023
Toxicity profile of antibody-drug conjugates in breast cancer: practical considerations
Andrea D'Arienzo, Annarita Verrazzo, Martina Pagliuca, et al.
Biomolecules
|
October 27, 2022
Insight on the Role of Leptin: A Bridge from Obesity to Breast Cancer
Roberto Buonaiuto, Fabiana Napolitano, Sara Parola, et al.
Cancer Treatment Reviews
|
August 20, 2022
Tailoring neoadjuvant treatment of HR-positive/HER2-negative breast cancers: Which role for gene expression assays?
Giovanna Garufi, Luisa Carbognin, Concetta Arcanà, et al.
International Journal of Molecular Sciences
|
July 20, 2021
The Enigmatic Role of TP53 in Germ Cell Tumours: Are We Missing Something?
Margaret Ottaviano, Emilio Francesco Giunta, Pasquale Rescigno, et al.
Frontiers in Oncology
|
February 26, 2021
A New Horizon of Liquid Biopsy in Thymic Epithelial Tumors: The Potential Utility of Circulating Cell-Free DNA
Margaret Ottaviano, Mario Giuliano, Marianna Tortora, et al.
International Journal of Molecular Sciences
|
April 3, 2021
BRAF Gene and Melanoma: Back to the Future
Margaret Ottaviano, Emilio Francesco Giunta, Marianna Tortora, et al.
Frontiers in Genetics
|
December 16, 2024
PARP inhibitors in testicular germ cell tumors: what we know and what we are looking for
Sara Parola, Christoph Oing, Pasquale Rescigno, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Exploration of Targeted Anti-Tumor Therapy
|
November 10, 2025
Bispecific antibodies in the treatment of epithelial ovarian, endometrial, and cervical cancer: an overview of current applications, challenges, and emerging opportunities
Sara Parola, Ilaria Colombo
Mediastinum (Hong Kong, China)
|
February 4, 2022
Mediastinal soft tissue sarcoma: dark sides and future lights
Giovannella Palmieri, Marianna Tortora, Sara Parola, et al.
Frontiers in Oncology
|
August 21, 2023
Long-term complete response with third-line PARP inhibitor after immunotherapy in a patient with triple-negative breast cancer: a case report
Roberta Caputo, Martina Pagliuca, Matilde Pensabene, et al.
Eclinicalmedicine
|
August 9, 2023
Toxicity profile of antibody-drug conjugates in breast cancer: practical considerations
Andrea D'Arienzo, Annarita Verrazzo, Martina Pagliuca, et al.
Biomolecules
|
October 27, 2022
Insight on the Role of Leptin: A Bridge from Obesity to Breast Cancer
Roberto Buonaiuto, Fabiana Napolitano, Sara Parola, et al.
Cancer Treatment Reviews
|
August 20, 2022
Tailoring neoadjuvant treatment of HR-positive/HER2-negative breast cancers: Which role for gene expression assays?
Giovanna Garufi, Luisa Carbognin, Concetta Arcanà, et al.
International Journal of Molecular Sciences
|
July 20, 2021
The Enigmatic Role of TP53 in Germ Cell Tumours: Are We Missing Something?
Margaret Ottaviano, Emilio Francesco Giunta, Pasquale Rescigno, et al.
Frontiers in Oncology
|
February 26, 2021
A New Horizon of Liquid Biopsy in Thymic Epithelial Tumors: The Potential Utility of Circulating Cell-Free DNA
Margaret Ottaviano, Mario Giuliano, Marianna Tortora, et al.
International Journal of Molecular Sciences
|
April 3, 2021
BRAF Gene and Melanoma: Back to the Future
Margaret Ottaviano, Emilio Francesco Giunta, Marianna Tortora, et al.
Frontiers in Genetics
|
December 16, 2024
PARP inhibitors in testicular germ cell tumors: what we know and what we are looking for
Sara Parola, Christoph Oing, Pasquale Rescigno, et al.
Page
of 2